Edgewise Therapeutics, Inc.
Pharmaceutical company · Boulder, Colorado, United States · Nasdaq: EWTX
Edgewise Therapeutics, Inc. is a pharmaceutical company headquartered in Boulder, Colorado, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker EWTX. It has reported private securities offerings to the US SEC, most recently $95 million sold in a notice filed in 2020.
Edgewise Therapeutics at a glance
What does Edgewise Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $95 million sold (2020).
Frequently asked questions about Edgewise Therapeutics
Where is Edgewise Therapeutics headquartered?
Edgewise Therapeutics, Inc. is headquartered in Boulder, Colorado, United States.
What does Edgewise Therapeutics do?
Edgewise Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Edgewise Therapeutics a public company?
Yes. Edgewise Therapeutics, Inc. trades on Nasdaq under the ticker EWTX.
When was Edgewise Therapeutics founded?
The earliest incorporation on record for Edgewise Therapeutics, Inc. is in 2017, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.